在患有急性心肌梗塞和心血管性休克患者的血管内成像引导的皮肤冠状动脉干预
Hyun Sung Joh1, Seung Hun Lee2, Jinhwan Jo3
1Department of Internal Medicine and Cardiovascular Center, Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Revista espanola de cardiologia (English ed.)
|April 12, 2024
概括
血管内成像指导的皮肤冠状动脉干预 (PCI) 在急性心肌梗塞 (AMI) 患有心脏性休克的患者中显著减少主要不良心血管事件 (MACE). 这种方法降低了心脏死亡的风险,与传统的血管学引导的PCI相比.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗成像医学成像
背景情况:
- 有限的临床数据存在于静脉内成像引导的皮肤穿透冠状动脉干预 (PCI) 与急性心肌梗塞 (AMI) 带有心脏性休克的血管学引导的PCI之间.
- 评估这种比较对于优化高风险心脏病患者的治疗策略至关重要.
研究的目的:
- 评估血管内成像指导PCI对患有心脏性休克复杂的AMI的患者临床结果的影响.
- 为了比较血管内成像对抗血管学PCI指导在这个特定的患者队列的疗效.
主要方法:
- 从全国综合登记处 (KAMIR-NIH和KAMIR-V) 进行了PCI的1833名AMI和心脏性休克患者的回顾性分析.
- 患者被分为血管内成像引导的PCI (n=375) 和血管学引导的PCI (n=1458) 组.
- 主要终点是1年的主要不良心血管事件 (MACE),包括心脏死亡,心肌梗塞,重复血管化和支架血栓形成. 倾向性得分匹配,反向概率加权和贝叶斯分析被用于调整.
主要成果:
- 血管内成像指导的PCI与血管造影指导的PCI (19.5%对28.2%;HR,0.59) 相比,与1年MACE的显著较低风险相关.
- 这种降低主要是由于成像指导组心脏病死亡风险显著降低 (13.7%vs24.0%;调整HR,0.53).
- 结果在各种统计调整方法中保持一致,包括倾向得分匹配和反向概率加权.
结论:
- 与血管内成像指导的PCI相比,在AMI和心脏性休克患者中,血管内成像指导的PCI显示出更高的安全性概况.
- 改善的结果主要归因于心脏病死亡率的降低,强调了复杂病例PCI期间增强可视化的好处.
相关概念视频
Imaging Studies for Cardiovascular System V: CT
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...


